nuke
Bluelighter
- Joined
- Nov 7, 2004
- Messages
- 4,191
The Discriminative Effects of Tramadol in Humans
This research is part of a set of studies whose purpose is to test whether tramadol can be used for the treatment of opioid addiction. Tramadol is already available in the United States as a pain medicine marketed as Ultram. It has effects similar to morphine, and it may also have effects similar to other drugs like stimulants. The doses of tramadol used in this study are higher than those generally used for the treatment of pain. To be in this study a participant must be a user of opioids (drugs like heroin) and stimulants (drugs like cocaine), but cannot be addicted to either. The person must be between 21-55 years old, and generally healthy. Up to 12 people will take part in this study.
Estimated Enrollment: 12
Study Start Date: November 2007
Estimated Study Completion Date: August 2009
Estimated Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Contacts
Contact: Sarah Ilk 410-550-0159 [email protected]
Contact: Eric C. Strain, M.D. [email protected]
Locations
United States, Maryland
Behavioral Pharmacology Research Unit Recruiting
Baltimore, Maryland, United States, 21224
Contact: Sarah Ilk 410-550-0159
Principal Investigator: Eric C. Strain, MD
http://www.clinicaltrials.gov/ct2/show/NCT00499746
This research is part of a set of studies whose purpose is to test whether tramadol can be used for the treatment of opioid addiction. Tramadol is already available in the United States as a pain medicine marketed as Ultram. It has effects similar to morphine, and it may also have effects similar to other drugs like stimulants. The doses of tramadol used in this study are higher than those generally used for the treatment of pain. To be in this study a participant must be a user of opioids (drugs like heroin) and stimulants (drugs like cocaine), but cannot be addicted to either. The person must be between 21-55 years old, and generally healthy. Up to 12 people will take part in this study.
Estimated Enrollment: 12
Study Start Date: November 2007
Estimated Study Completion Date: August 2009
Estimated Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)
Contacts
Contact: Sarah Ilk 410-550-0159 [email protected]
Contact: Eric C. Strain, M.D. [email protected]
Locations
United States, Maryland
Behavioral Pharmacology Research Unit Recruiting
Baltimore, Maryland, United States, 21224
Contact: Sarah Ilk 410-550-0159
Principal Investigator: Eric C. Strain, MD
http://www.clinicaltrials.gov/ct2/show/NCT00499746
Last edited by a moderator: